Autonomix Medical’s CEO Brad Hauser will deliver a live presentation at LSI USA ’26 on March 17 at 9:15 AM PT in The Woodlands, TX. Management will also host in-person one-on-one meetings for qualified, registered investors during the conference to discuss strategy and technology progress.

The company’s platform uses a catheter-based microchip sensing array designed to detect and differentiate neural signals for transvascular diagnosis and treatment. Initial clinical development focuses on alleviating pancreatic cancer pain, with the technology’s platform potential extending to cardiology, hypertension and chronic pain management once cleared for marketing.